Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00585975 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Bromfenac Ophthalmic Solution
A Phase 2 study of Cataract Surgery, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 2
- Development phase
- 568
- Enrollment target
- 1
- Study location
NCT00585975: Completed Phase 2 study of Cataract Surgery, sponsored by Bausch & Lomb Incorporated.
NCT00585975 is a Phase 2 study of Cataract Surgery that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 568 participants, above the 65-participant average among 7 other Cataract Surgery trials with a reported enrollment target (774% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00585975, a Phase 2 study of Cataract Surgery, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 568 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a safety and efficacy study of bromfenac ophthalmic solution
Primary Outcome
Participants with SOIS of 1. Scale: 0=0 cells (complete absence); 0.5=1-5 cells (trace); 1=6-15 cells (very slight); 2=16-25 cells (moderate); 3=26-50 cells (marked); 4=\>50 cells (intense)
Conditions Studied
Interventions
- DRUG bromfenac ophthalmic solution
Study Locations (1)
California
- ISTA Pharmaceuticals, Inc. - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 568 participants |
| Start Date | 2007-10 |
| Phase | Phase 2 |
What the finished NCT00585975 record still lists
NCT00585975 is an interventional study that assigns participants to a tested intervention. The registered 568 participants enrollment target is mid-sized for trials with a published cap, above the 65-participant average among 7 other Cataract Surgery trials with a reported enrollment target (774% higher).
The record links to 1 condition, with Cataract Surgery appearing as the primary indexed condition, and to 1 intervention - of which bromfenac ophthalmic solution is the first listed.
NCT00585975 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00585975 about?
NCT00585975 is a clinical study titled "Efficacy and Safety of Bromfenac Ophthalmic Solution". This is a safety and efficacy study of bromfenac ophthalmic solution
What is the current status of trial NCT00585975?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 568 participants. The study started on 2007-10.
What conditions does trial NCT00585975 study?
This clinical trial studies the following conditions: Cataract Surgery.
What interventions are being tested in trial NCT00585975?
The interventions under investigation include: bromfenac ophthalmic solution (DRUG).
Who is sponsoring clinical trial NCT00585975?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00585975 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety and Workflow Study
RECRUITING · NA
-
Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients
RECRUITING
-
Remimazolam for Cataract Surgery
RECRUITING · Phase 4
-
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
COMPLETED · NA
-
Omidria and Dexycu, or Omidria and Dextenza Compared to Topical Prednisolone Acetate 1% Following Cataract Surgery
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05472441 · 568 participants · NA
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia